Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $40.61 | $40.35 | -0.64% | 0.0M |
| 05-12 | $40.41 | $40.01 | -0.99% | 0.1M |
| 05-13 | $39.88 | $40.15 | +0.68% | 0.1M |
| 05-14 | $40.29 | $40.76 | +1.17% | 0.1M |
| 05-15 | $40.45 | $40.26 | -0.46% | 0.1M |
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
| Metric | Q1 2019 2019-03-31 | Annual 2018 2018-12-31 | Q3 2018 2018-09-30 | Q2 2018 2018-06-30 |
|---|---|---|---|---|
Revenue | $2.20M | $9.20M | $6.80M | $4.40M |
Operating Income | $6.22M | $26.70M | $20.25M | $13.75M |
Net Income | $4.21M | $24.20M | $4.37M | $5.80M |
EPS (Diluted) | $0.31 | $1.76 | $0.32 | $0.42 |
Total Assets | $489.05M | $483.76M | $487.56M | $491.00M |
Total Liabilities | $295.42M | $285.15M | $284.20M | $283.01M |
Cash & Equivalents | $6.03M | $5.04M | $5.07M | $5.73M |
Free Cash Flow OCF − CapEx | Not available | $38.88M | $29.19M | $19.16M |
Shares Outstanding | 13.75M | 13.75M | 13.75M | 13.74M |